Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.
Hillman
A L
AL
Eisenberg
J M
JM
Pauly
M V
MV
Bloom
B S
BS
Glick
H
H
Kinosian
B
B
Schwartz
J S
JS
D003362:Cost-Benefit Analysis; D004345:Drug Industry; D004995:Ethics, Professional; D011287:Prejudice; D012107:Research Design; D014481:United States